{"target": "http://pubannotation.org/docs/sourcedb/PubMed//sourceid/10192393", "sourcedb": "PubMed", "sourceid": "10192393", "text": "A common human skin tumour is caused by activating mutations in beta-catenin.\n\nWNT signalling orchestrates a number of developmental programs. In response to this stimulus, cytoplasmic beta-catenin (encoded by CTNNB1) is stabilized, enabling downstream transcriptional activation by members of the LEF/TCF family. One of the target genes for beta-catenin/TCF encodes c-MYC, explaining why constitutive activation of the WNT pathway can lead to cancer, particularly in the colon. Most colon cancers arise from mutations in the gene encoding adenomatous polyposis coli (APC), a protein required for ubiquitin-mediated degradation of beta-catenin, but a small percentage of colon and some other cancers harbour beta-catenin-stabilizing mutations. Recently, we discovered that transgenic mice expressing an activated beta-catenin are predisposed to developing skin tumours resembling pilomatricomas. Given that the skin of these adult mice also exhibits signs of de novo hair-follicle morphogenesis, we wondered whether human pilomatricomas might originate from hair matrix cells and whether they might possess beta-catenin-stabilizing mutations. Here, we explore the cell origin and aetiology of this common human skin tumour. We found nuclear LEF-1 in the dividing tumour cells, providing biochemical evidence that pilomatricomas are derived from hair matrix cells. At least 75% of these tumours possess mutations affecting the amino-terminal segment, normally involved in phosphorylation-dependent, ubiquitin-mediated degradation of the protein. This percentage of CTNNB1 mutations is greater than in all other human tumours examined thus far, and directly implicates beta-catenin/LEF misregulation as the major cause of hair matrix cell tumorigenesis in humans.. \n", "project": "NCBI-Disease-train", "denotations": [{"id": "T1", "obj": "DiseaseClass", "span": {"begin": 15, "end": 26}}, {"id": "T2", "obj": "DiseaseClass", "span": {"begin": 444, "end": 450}}, {"id": "T3", "obj": "DiseaseClass", "span": {"begin": 484, "end": 497}}, {"id": "T4", "obj": "SpecificDisease", "span": {"begin": 540, "end": 566}}, {"id": "T5", "obj": "SpecificDisease", "span": {"begin": 567, "end": 571}}, {"id": "T6", "obj": "CompositeMention", "span": {"begin": 671, "end": 699}}, {"id": "T7", "obj": "DiseaseClass", "span": {"begin": 856, "end": 868}}, {"id": "T8", "obj": "SpecificDisease", "span": {"begin": 880, "end": 894}}, {"id": "T9", "obj": "SpecificDisease", "span": {"begin": 1022, "end": 1036}}, {"id": "T10", "obj": "DiseaseClass", "span": {"begin": 1211, "end": 1222}}, {"id": "T11", "obj": "Modifier", "span": {"begin": 1263, "end": 1269}}, {"id": "T12", "obj": "SpecificDisease", "span": {"begin": 1313, "end": 1327}}, {"id": "T13", "obj": "DiseaseClass", "span": {"begin": 1386, "end": 1393}}, {"id": "T14", "obj": "DiseaseClass", "span": {"begin": 1616, "end": 1623}}], "attributes": [{"pred": "MEDIC", "id": "A1", "subj": "T1", "obj": "D012878"}, {"pred": "MEDIC", "id": "A2", "subj": "T2", "obj": "D009369"}, {"pred": "MEDIC", "id": "A3", "subj": "T3", "obj": "D003110"}, {"pred": "MEDIC", "id": "A4", "subj": "T4", "obj": "D011125"}, {"pred": "MEDIC", "id": "A5", "subj": "T5", "obj": "D011125"}, {"pred": "MEDIC", "id": "A6", "subj": "T7", "obj": "D012878"}, {"pred": "MEDIC", "id": "A7", "subj": "T8", "obj": "D018296"}, {"pred": "MEDIC", "id": "A8", "subj": "T9", "obj": "D018296"}, {"pred": "MEDIC", "id": "A9", "subj": "T10", "obj": "D012878"}, {"pred": "MEDIC", "id": "A10", "subj": "T11", "obj": "D009369"}, {"pred": "MEDIC", "id": "A11", "subj": "T12", "obj": "D018296"}, {"pred": "MEDIC", "id": "A12", "subj": "T13", "obj": "D009369"}, {"pred": "MEDIC", "id": "A13", "subj": "T14", "obj": "D009369"}]}